Litcius/Paper detail

Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group

Heidi D. Finnes, Berrie Child, Sean DeFrates, Katharine Kinsman, Andrew Thorne, Sarah Lentz, Robin Lockhorst, Jennifer Murphy, Angela Urmanski, Sapna Amin, Hallie Barr, Sunanda Baviskar, Carrie Beckman, Nicholas Chow, Megan Derba, Marsha K. Erickson, Emily R Hennes, Heather D. Heisey, Rebecca Lau, Suwicha Limvorasak, Todd Luckritz, Theresa A. Mays, Chukwuemeka N Nzelibe, Tracy Romanowski, Camille M. Smith, Debra Tesoro, Katelyn Toeniskoetter, Krista Voytilla

2022American Journal of Health-System Pharmacy24 citationsDOIOpen Access PDF

Abstract

In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

Topics & Concepts

PharmacyPreparednessMedicineCoronavirus disease 2019 (COVID-19)Investigational DrugsPandemicMedical physicsOncologyMedical educationInternal medicineFamily medicineClinical trialDiseasePolitical scienceInfectious disease (medical specialty)LawEthics in Clinical ResearchCOVID-19 and healthcare impactsBiomedical Ethics and Regulation
Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group | Litcius